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Aims: In the NOD-like receptor (NLR) family, the pyrin domain containing 3 (NLRP3)
inflammasome is closely related to the progression of atherosclerosis. This study aimed
to assess the effects of curcumin on NLRP3 inflammasome in phorbol 12-myristate 13-
acetate (PMA)-induced macrophages and explore its underlying mechanism.
Methods: Human monocytic THP-1 cells were pretreated with curcumin for 1 h and
subsequently induced with PMA for 48 h. Total protein was collected for Western
blot analysis. Cytokine interleukin (IL)-1β release and nuclear factor kappa B (NF-κB)
p65 translocation were detected by ELISA assay and cellular NF-κB translocation kit,
respectively.
Results: Curcumin significantly reduced the expression of NLRP3 and cleavage of
caspase-1 and IL-1β secretion in PMA-induced macrophages. Moreover, Bay (a NF-κB
inhibitor) treatment considerably suppressed the expression of NLRP3 inflammasome
in PMA-induced THP-1 cells. Curcumin also markedly inhibited the upregulation of toll-
like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), phosphorylation level
of IκB-α, and activation of NF-κB in PMA-induced macrophages. In addition, purinergic
2X7 receptor (P2X7R) siRNA was administered, and it significantly decreased NLRP3
inflammasome expression in PMA-induced macrophages. Furthermore, curcumin
reversed PMA-stimulated P2X7R activation, which further reduced the expression of
NLRP3 and cleavage of caspase-1 and IL-1β secretion. Silencing of P2X7R using siRNA
also suppressed the activation of NF-κB pathway in PMA-induced macrophages, but
P2X7R-silenced cells did not significantly decrease the expression of TLR4 and MyD88.
Conclusion: Curcumin inhibited NLRP3 inflammasome through suppressing
TLR4/MyD88/NF-κB and P2X7R pathways in PMA-induced macrophages.
Keywords: Curcumin, NLRP3 inflammasome, TLR4/MyD88/NF-κB, P2X7R, macrophages
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INTRODUCTION
Atherosclerosis is a chronic and progressive immunoinfla-
mmatory disease. Monocytes are one of major factors in the
development of this disease. Focal recruitment of circulating
monocytes is one of the earliest cellular responses, which underlie
disease progression. Moreover, inflammatory factors, which are
released by the newly differentiated macrophages, play key roles
in the pathophysiology of atherosclerosis (Glass and Witztum,
2001; Libby, 2002; Hansson, 2005).
For the NOD-like receptor (NLR) family, the pyrin domain
containing 3 (NLRP3) inflammasome plays a crucial role in the
inflammatory response (Schroder and Tschopp, 2010). NLRP3
inflammasome is a multiprotein complex that consists of NLRP3,
an apoptosis-associated speck-like protein containing a caspase
recruitment domain (ASC) and caspase-1 (Latz et al., 2013).
Upon stimulation, NLRP3 recruits its adaptor ASC and pro-
caspase-1 to form an inflammasome complex; consequently,
caspase-1 is activated, which causes the cleavage of the pro-
forms of interleukin (IL)-1β and IL-18 to their mature forms
(Martinon et al., 2009). Moreover, cholesterol crystals induce
NLRP3 inflammasome activation and IL-1β secretion in human
macrophages (Duewell et al., 2010; Rajamaki et al., 2010). IL-
1β is a fundamental pro-inflammatory cytokine in mediating
atherosclerosis progression (Elhage et al., 1998; Duewell et al.,
2010).
Curcumin, a natural polyphenolic compound in Curcuma
longa, exhibits various biological properties, including anti-
inflammatory, antioxidant, and anti-infection (Shishodia, 2013).
Briefly, curcumin administration has been previously associated
to regulate different inflammatory cytokines, such as IL-1β
(Sun et al., 2013), extracellular matrix metalloproteinase inducer,
and matrix metalloproteinase-9 expression (Cao et al., 2014).
In addition, the effect of curcumin is associated with the
inhibition of different signaling pathway activations, including
the activation of toll-like receptor 4 (TLR4), nuclear factor kappa
B (NF-κB), and mitogen-activated protein kinase pathways (Min
et al., 2013; Zhou et al., 2015). However, whether the anti-
atherogenic effects of curcumin involve in suppressing NLRP3
inflammasome activation has never been indicated.
Hence, the present study aims to: (i) identify the expression
of NLRP3 inflammasomes under curcumin treatment in
monocytes/macrophages; and (ii) elucidate the relative
mechanism of curcumin treatment on the inflammatory
activity of monocytes/macrophages.
MATERIALS AND METHODS
Cell Culture
Human monocytic cell line (THP-1) was obtained from
the American Type Culture Collection (Rockville, MD,
USA) and maintained at a density of 106/ml in RPMI 1640
medium containing 10% fetal bovine serum (FBS), 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
(Sigma–Aldrich, USA), and 1% pen/strep solution at 37◦C in a
5% CO2 incubator. The cells were cultured in 6-well plates for
48 h in the presence of 100 nM phorbol 12-myristate 13-acetate
(PMA), which allowed them to differentiate into adherent
macrophages. Cells were stimulated for 1 h with curcumin
(0–50 µM, Sigma–Aldrich, USA) or 5 µM Bay 11-7082 (NF-κB-
specific inhibitor; Beyotime Biotech, China) and subsequently
treated with PMA for another 48 h.
Determination of Cell Viability (CCK8
Assay)
CCK8 assay (WST-8, Dojindo, Kumamoto, Japan) was used
to evaluate the cytotoxicity of curcumin on PMA-induced
macrophages, according to the manufacturer’s recommendation.
PMA-induced macrophages were seeded in 96-well plates at
6 × 103 cells/well. At 24 h later, cells were incubated with
curcumin (0–100 µM) for 48 h.
siRNA Transfection
Cells were transfected with 20 nM of siRNA for 8 h with
siRNA transfection reagent (RiboBio, Guangzhou, China) to
knockdown purinergic 2X7 receptor (P2X7R). Briefly, cells
were treated with 100 nM of PMA for 48 h and washed in
fresh medium without antibiotics. Afterward, the cells were
treated with siRNA duplex solution for 8 h. The medium was
subsequently replaced with normal culture medium. Control
cells were transfected with scrambled sequence siRNA control
(RiboBio, Guangzhou, China). The cell lysates were utilized for
Western blot analysis to verify the efficacy of protein knockdown
by siRNA.
Western Blotting
Protein isolation and Western blot analysis were performed
comparably, as described in literature (Huang et al., 2011).
Briefly, membrane protein samples were subjected to sodium
dodecyl sulfate–polyacrylamide gel electrophoresis and blotted
onto a polyvinylidene difluoride membrane (Bio-Rad, Hercules,
CA, USA). The membranes were blocked with 5% milk at room
temperature and incubated at 4◦C overnight with NLRP3, IL-
1β, P65, phospho-P65, P-IκB-α, IκB-α, GAPDH, P2X7R, Bax,
Bcl-2 (Cell Signaling Technology, Boston, MA, USA) (1:1000
dilution in TBST) or TLR4, and MyD88 (Abcam, Cambridge,
MA, UK) (1:500 dilution in TBST) or caspase-1 (Santa Cruz,
CA, USA) (1:500 dilution in TBST). Proteins were visualized with
ECL procedure (Bio-Rad, USA). The results were analyzed using
Quantity One (Bio-Rad) software.
ELISA for Cytokine Measurements
Cytokines were measured by ELISA in 48-h culture supernatants.
On this basis, cells were preincubated in the presence or
absence of curcumin (6.25–25 µM) for 1 h or 5 µM Bay 11-
7082 (NF-κB-specific inhibitor) for 30 min. PMA was added
to the cells at a final concentration of 100 nM, and the
cells were further incubated for 48 h. Culture supernatants
were analyzed to determine IL-β concentrations using sandwich
enzyme immunoassay kits (R&D Systems Europe Ltd, Abingdon,
UK), according to the manufacturer’s instructions.
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FIGURE 1 | Effects of curcumin on cell viability and apoptosis. THP-1 monocytes were incubated with various curcumin concentrations (0–100 µM) for 1 h
and exposed to 100 nM of phorbol 12-myristate 13-acetate (PMA) for 48 h. (A) Cell proliferation was assessed using the CCK8 assay. Cells incubated in a medium
without curcumin and PMA were defined as control and considered to have a 100% proliferation rate. (B) Chemical structure of curcumin. (C) Representative
Western blot analysis of Bax and Bcl-2 in curcumin (6.25–25 µM)-treated THP-1 cells. (D) Densitometric analysis was used to quantify the ratio of Bax/Bcl-2. The
results represent the mean ± SEM for three experiments. ∗P < 0.05 vs. PMA group, #P < 0.05 vs. Control group.
Immunofluorescence Staining of NF-κB
p65
Human monocytic THP-1 cells were cultured on 20-mm
diameter glass coverslips in 12-well plates. Cells were pretreated
with curcumin (6.25–25 µM) for 1 h and subsequently
treated with PMA (100 nM) or vehicle control for 48 h.
The cells were immunofluorescence-labeled using a cellular
NF-κB translocation kit (Beyotime Biotech), according to the
manufacturer’s protocol. Briefly, after washing and fixing, the
cells were incubated with a blocking solution at 4◦C overnight
and subsequently with the NF-κB p65 antibody for 2 h. After
washing thrice, a rabbit IgG antibody conjugated with Cy3 was
added and incubated for 1 h. To stain the nucleus, the cells
were incubated with 4′,6-diamidino-2-phenylindole (DAPI) for
5 min. The activation of NF-κB p65 was visualized with an
inverted fluorescence microscope (Olympus DP70) at excitation
wavelengths of 350 and 540 nm for DAPI and Cy3, respectively.
The red and blue images were overlaid to create a two-color
image, in which purple fluorescence indicated the areas of
colocalization.
Statistical Analysis
All values were expressed as mean ± SEM. One-way ANOVA
and subsequent post hoc Tukey’s test were employed to analyze
the differences between sets of data. Statistics was analyzed using
the SPSS 20.0 software. Values of P < 0.05 were considered
statistically significant.
RESULTS
Effects of Curcumin on Cell Viability and
Apoptosis
We first examined the effect of curcumin on the viability of
PMA-induced THP-1 cells. PMA-induced macrophages were
treated with curcumin (6.25–100 µM) or the vehicle for
48 h. Cell viability was assessed using the CCK8 assay. As
shown in Figure 1A, curcumin at 50 µM significantly reduced
cell viability after 48 h of incubation compared with control
ethanol. On this basis, the experiments in cultured THP-1 cells
were conducted using 6.25, 12.5, and 25 µM of curcumin.
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FIGURE 2 | Curcumin attenuates the activation of the NOD-like receptor (NLR) family, pyrin domain containing 3 (NLRP3) inflammasome. THP-1
macrophages were stimulated by incubation with curcumin (Cur) at the indicated concentration (6.25–25 µM) for 1 h, followed by PMA for 48 h. The condition
referred to as control refers to THP-1 treated with vehicle or dimethyl sulfoxide (DMSO) for 48 h. (A) Representative Western blot analysis of NLRP3 and the cleavage
of caspase-1 and interleukin (IL)-1β protein expression after PMA-induced inflammasome activation. (B) Densitometric analysis was used to quantify the level of
NLRP3 and cleavage of caspase-1 and IL-1β. (C) Concentrations of IL-1β in cell culture supernatants were detected by ELISA. The results represent the
mean ± SEM for three experiments. ∗P < 0.05 vs. PMA group, #P < 0.05 vs. Control group.
The structure of curcumin used in this study is shown in
Figure 1B.
To confirm the effect of curcumin on the apoptosis of
PMA-induced macrophages, we explored the effect of Bax and
Bcl-2 expression by Western blot analysis (Figures 1C,D).
Significantly, cucurmin-treated cells showed dose-dependent
reduction of Bax/Bcl-2 ratio.
Curcumin Attenuates the Activation of
the NLRP3 Inflammasome
To examine the effect of curcumin on NLRP3 inflammasome
activation, we stimulated THP-1 cells with PMA in the presence
or absence of curcumin. Results displayed that curcumin
effectively reduced the cleavage and secretion of IL-1β level in
a dose-dependent manner (Figures 2A–C). Upon activation,
NLRP3, which contains a caspase recruitment domain, causes
the cleavage of pro-caspase-1, an essential step to produce
and release IL-1β (Schroder and Tschopp, 2010). Consistently,
western blot analysis confirmed the reduction of cleaved
caspase-1 (p10) and NLRP3 inflammasome level by curcumin
(Figures 2A,B). These observations suggested that curcumin
effectively attenuated the cleavage and secretion of IL-1β level,
at least partially, via the inhibition of NLRP3 inflammasome
activation.
NF-κB Pathway Is Involved in the
Activation of the NLRP3 Inflammasome
in PMA-Induced Macrophages
To investigate the associated mechanism of curcumin effect on
NLRP3 inflammasome, cells were pre-incubated with 5 µM Bay
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FIGURE 3 | Nuclear factor kappa B (NF-κB) pathway activation participates in the activation of the NLRP3 inflammasome in PMA-induced
macrophages. Cells were incubated with 6.25 µM of curcumin (Cur) for 1 h or 5 µM of NF-κB specific inhibitor Bay 11-7082 (Bay) for 30 min and exposed to
100 nM of PMA for 48 h before collection. (A) Representative Western blot analysis of NLRP3 and the cleavage of caspase-1 and IL-1β protein expression after
PMA-induced inflammasome activation. (B) Densitometric analysis was used to quantify the level of NLRP3 and cleavage of caspase-1 and IL-1β. The results
represent the mean ± SEM for three experiments. ∗P < 0.05 vs. PMA group, #P < 0.05 vs. Control group.
11-7082 (NF-κB pathway inhibitor) for 30 min before PMA
addition. When cells were cultured in the presence of Bay 11-
7082, complete inhibition of NLRP3 expression and cleavage
of caspase-1 and IL-1β secretion were observed, which were
congruent with the curcumin-pretreated groups (Figures 3A,B
and 2C). This result suggested that suppression of NF-κB-
signaling pathway activation mitigated NLRP3 inflammasome in
PMA-induced macrophages.
Curcumin Inhibits the Activation of the
TLR4/MyD88/NF-κB-Signaling Pathways
Rapidly growing evidence presented that the TLR4/NF-κB signal
transduction pathway is considered an early event essential
for inflammasome activation and subsequent IL-1β secretion
(Bauernfeind et al., 2009). NLRP3 inflammasome activation
during pathological conditions also involves TLR signaling;
thus, we monitored the changes in TLR4 expression in PMA-
induced THP-1 cells and noticed that PMA stimulation increased
the expression of TLR4, which was not observed in control
group (Figure 4A). Quantification of Western blots showed
that TLR4 expression level was reduced in a dose-dependent
manner in curcumin treatment group (Figures 4A,B). TLR
signaling involves the recruitment of MyD88 adapter protein and
final activation of NF-κB (Barton and Medzhitov, 2003); hence,
we examined the expression of these associated downstream-
signaling molecules in cell cultures by Western blot analysis.
PMA increased the expression of TLR4 and MyD88, as well
as the phosphorylation level of IκB-α and nuclear p65 in
the THP-1 cells (Figure 4A). Curcumin treatment effectively
downregulated the PMA-induced upregulation of TLR4 and
MyD88, and phosphorylation level of IκB-α and p65 subunit
of NF-κB (Figures 4A–E). Additionally, curcumin reduced the
nuclear localization of p65 (Figure 4F). Taken together, the
results implied that curcumin-modulated TLR4/MyD88/NF-
κB signalings during PMA stimulation in a dose-depended
manner.
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FIGURE 4 | Curcumin inhibits the activation of the TLR4/MyD88/NF-κB-signaling pathways. (A) Representative Western blot analysis of TLR4, MyD88,
p-IκB-α, IκB-α, p-P65, and P65 was normalized based on the internal control GAPDH. (B–E) Densitometry measurements of protein analysis. The results represent
the mean ± SEM for three experiments. ∗P < 0.05 vs. PMA group, #P < 0.05 vs. Control group. (F) Differentiated THP-1 cells were treated with indicated agent’s
immunostained with DAPI (Blue) and anti-NF-κB p65 (Red) and observed using an inverted fluorescence microscope, 200×.
Curcumin Decreases the Expression of
P2X7R in PMA-Induced Macrophages
Purinergic 2X7 receptor is essential for activating the NLRP3
inflammasome (Di Virgilio, 2007). Therefore, we hypothesized
that curcumin inhibited the activation of the NLRP3
inflammasome via the mechanism of P2X7R. First, P2X7R
siRNA was administered to knock-down the P2X7R expression
of PMA-induced macrophages. We successfully and markedly
decreased basal P2X7R expression (Figures 5A,B). Our data
indicated that P2X7R-silenced cells significantly attenuated the
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FIGURE 5 | Curcumin decreases the expression of P2X7R in PMA-induced macrophages. (A,B) THP-1 cells silenced for purinergic 2X7 receptor (P2X7R)
were processed to obtain a whole-cell extract as described under the Section “Materials and Methods”. The expression of P2X7R in cells were transfected with
P2X7R or negative control (NC) siRNA. (C,D) The expression of NLRP3 and cleavage of caspase-1 and IL-1β in cells were transfected with P2X7R or negative
control (NC) siRNA. (E,F) THP-1 cells were pretreated with curcumin in the presence of PMA for 48 h. The expression of P2X7R was determined by Western blot
analysis. ∗P < 0.05 vs. PMA group, #P < 0.05 vs. Control group.
activation of caspase-1, which was evidenced by decreased IL-1β
production. However, P2X7R-silenced cells did not significantly
decrease the expression of NLRP3 (Figures 5C,D). Second, we
investigated the interaction between curcumin and P2X7R in
PMA-induced macrophages. Curcumin inhibited the expression
of P2X7R in a dose-dependent manner (Figures 5E,F). Our data
indicated that curcumin can inhibit the NLRP3 inflammasomes
via (at least patially) decreasing P2X7R.
P2X7R Activation Regulates Nuclear
Translocation of NF-κB in PMA-Induced
Macrophages
To clarify the relationship of P2X7R on the regulation
of TLR4/MyD88/NF-κB signalings, we further used P2X7R-
silenced cells by siRNA. Our result showed that P2X7R-silenced
cells significantly decreased the phosphorylation level of p65
subunit of NF-κB. Nevertheless, the expression of TLR4 and
MyD88 (Figures 6A–C) was not significantly changed. This
finding indicated that P2X7R activation was only involved in
regulating the nuclear translocation of NF-κB in PMA-induced
macrophages.
DISCUSSION
In this research, curcumin effectively suppressed the expression
of NLRP3 inflammasome in PMA-induced macrophages.
Moreover, in PMA-induced macrophages, TLR4/MyD88/NF-κB
and P2X7R pathways were necessary for the inhibition of
NLRP3 inflammasome expression by curcumin. Therefore, these
results supported a novel effect of curcumin on the expression
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FIGURE 6 | Purinergic 2X7 receptor inhibition reduces the phosphorylation of p65 in PMA-induced macrophages. THP-1 cells silenced for P2X7R were
used to obtain a whole-cell extract as described under Materials and Methods. (A) Representative Western blot analysis of TLR4, MyD88, p-P65, and P65 was
normalized based on the internal control GAPDH. (B,C) Densitometry measurements of protein analysis. The results represent the mean ± SEM for three
experiments. ∗P < 0.05 vs. PMA group.
FIGURE 7 | Schematic model for the reduction of NLRP3
inflammasome expression in PMA-stimulated macrophages treated
with curcumin. The curcumin-downregulated P2X7R expression and
TLR4/MyD88/NF-κB signaling, which together inhibited NLRP3 expression,
caspase-1 activation, and the secretion of IL-1β.
of NLRP3 inflammasome, which suggested curcumin as a
promising therapeutic agent for ameliorating the development of
atherosclerosis.
Monocytes play a key role in invading atherosclerotic
lesions and differentiating them into macrophages (Boyle,
2005; Johnson and Newby, 2009). Plaque-residing macrophages
produce chemokines/cytokines, such as IL-1β, which further
regulate monocyte/T-cell infiltration into the lesion (Zernecke
et al., 2008). PMA-induced IL-1β production is dependent
on the NLRP3 inflammasome (Tulk et al., 2015), thereby
suggesting that NLRP3 inflammasome can prevent mature
IL-1β production. In addition, Zheng et al. (2014) showed that
knocking down NLRP3 genes in apolipoprotein E-deficient
mice results in reduced inflammatory cytokines and plaque
content of lipid and macrophages, as well as increased
plaque content of collagen; therefore, NLRP3 is associated
with unstable qlaque of atherosclerosis. In our study, PMA
treatment-induced NLRP3 inflammasome and the cleavage
of caspase-1 and IL-1β expression; moreover, curcumin
treatment could markedly mitigate the expression of NLRP3
inflammasome, as well as the cleavage of caspase-1 and
IL-1β expression. These findings inferred that curcumin
exhibits its anti-inflammatory activity through suppressing
the expression of NLRP3 inflammasome in PMA-induced
macrophages.
Toll-like receptor 4, which is broadly expressed on the plasma
membranes of immune cells, plays a vital role in initiating
the sterile inflammation related to atherosclerosis (Guo et al.,
2015; Luo et al., 2015). Within the TLR4-signaling pathway, the
MyD88-dependent signaling pathway is an important activator of
NF-κB and the subsequent regulatory effects of NF-κB signaling
(Barton and Medzhitov, 2003). In our study, the expression of
TLR4 and MyD88 protein, phosphorylation level of IκB-α and
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NF-κB p65, and nuclear localization of p65 were significantly
increased at 48 h after PMA stimulation compared with the
control group. Curcumin treatment obviously suppressed all
these indicators. Moreover, Bay 11-7082 (a NF-κB-specific
inhibitor) markedly reduced NLRP3 inflammasome activation,
which was dramatically attenuated by curcumin treatment.
Considering these findings, we suggested the protective effects
of curcumin against NLRP3 inflammasome activation by
regulating the TLR4/MyD88/NF-κB signaling in PMA-induced
macrophages.
Purinergic 2X7 receptor, a member of the P2X subfamily, plays
an important role in macrophage regulating cytokine production,
which is activated by extracellular ATP to induce NLRP3
inflammasome assembly and caspase-1-dependent processing,
and release of pro-inflammatory cytokines IL-1β and IL-
18 (Di Virgilio, 2007; Franceschini et al., 2015; Gicquel
et al., 2015). P2X7R activation can also activate the NLRP3
inflammasome to promote the progression of atherosclerosis
(Piscopiello et al., 2013; Peng et al., 2015). To confirm
whether curcumin inhibited NLRP3 inflammasome activation
through P2X7R-signaling cascade, the receptor was silenced. As
expected, siRNA interference of P2X7R significantly impaired
NLRP3 inflammasome activation and IL-1β secretion in
PMA-induced THP-1 cells; this result was consistent with
the results of Peng et al. (2015). In addition, curcumin
significantly inhibited PMA-induced P2X7R expression in
macrophages. These results showed that curcumin reduced
the activation of NLRP3 inflammasome via regulating P2X7R
in PMA-induced THP-1 cells. P2X7R-silenced cells could also
decrease the phosphorylation level of p65 subunit of NF-
κB, but not TLR4 or MyD88 pathway in PMA-induced
THP-1 cells; this observation indicated the activation of p65
is a common downstream of TLR4/MyD88 and P2X7R-
signaling pathways. Together, curcumin-downregulated P2X7R
expression and TLR4/MyD88/NF-κB signaling regulated the
NLRP3 expression, caspase-1 activation, and IL-1β secretion in
PMA-induced macrophages.
Indeed previous reports suggest that curcumin can inhibit
the NLRP3 inflammasome activation and subsequent release of
mature IL-1β both in J774A.1 cells, as well as murine peritoneal
macrophages in in vivo experiments (Gong et al., 2015). One
important difference between our study and that of Gong
et al. (2015) is the focus on treatment of cell models. Gong
et al. (2015) measured NLRP3 inflammasome production, which
was subsequently stimulated with lipopolysaccharide combined
with multiple NLRP3 inflammasome activators in mouse
macrophages. Additionally, we detected NLRP3 inflammasome
production in THP-1 cells stimulated with PMA, which imitated
the process of monocyte differentiation to macrophages, which is
important for atherosclerosis development. Another important
difference is the signaling pathway; they showed that inhibition
of NLRP3 inflammasome activation by curcumin involves the
downregulation of ERK signaling. We observed that inhibition
of NLRP3 inflammasome activation by curcumin involves the
downregulation of TLR4/MyD88/NF-κB- and P2X7R-signaling
pathways. Altogether, the results of Gong et al. and the present
study strongly implicated curcumin as a potent antagonist of
NLRP3 inflammasome activation in different pathophysiological
processes.
Given the effect of curcumin on the expression of
NLRP3 inflammasome and regulation of TLR4/MyD88/NF-
κB and P2X7R, we concluded that curcumin reduced NLRP3
inflammasome, cleaved caspase-1 induction, and consequently
reduced IL-1β secretion through TLR4/MyD88/NF-κB and
P2X7R pathways in PMA-induced macrophages; the schematic
model is shown in Figure 7. This study suggested that
curcumin might act as an effective candidate for inflammation
in atherosclerosis and have advantages for potential clinical
applications.
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